Deutsche Biotech Innovativ AG

MUN:DBI Stock Report

Market Cap: €1.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Deutsche Biotech Innovativ Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Bernd Wegener

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Bernd Wegener (77 yo)

no data

Tenure

Dr. Bernd Wegener, FRICS, serves as the Chairman of Management Board and Chief Executive Officer at Deutsche Biotech Innovativ AG. Dr. Wegener served as Chairman of the Supervisory Board of Adrenomed AG un...